Angion Biomedica Corp. SBIR Phase I Award, April 2019
A SBIR Phase I contract was awarded to Angion Biomedica Corp. in April, 2019 for $220,731.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Currently, there are no issues on this topic.
Find more entities like Angion Biomedica Corp. SBIR Phase I Award, April 2019
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.